| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | A O SMITH | 2,700 | 207,000 | 0.03% | ||
| 2 | ISRAEL CHEMICALS LTD SHS | 69,083 | 280,000 | 0.04% | ||
| 3 | GENVEC INC | 186,500 | 343,000 | 0.05% | ||
| 4 | Life Technologies Corp | 36,450 | 358,000 | 0.05% | ||
| 5 | BIOMARIN PHARMACEUTICAL INC | 3,700 | 388,000 | 0.06% | ||
| 6 | EZCHIP SEMICONDUCTOR F | 20,447 | 505,000 | 0.07% | ||
| 7 | Catabasis Pharmaceuticals Inc | 80,742 | 640,000 | 0.09% | ||
| 8 | Former Charter Communication (Del 5/18/2016) | 4,026 | 737,000 | 0.11% | ||
| 9 | WIX COM LTD | 35,460 | 807,000 | 0.12% | ||
| 10 | ELLOMAY CAPITAL LIMITED | 95,653 | 824,000 | 0.12% | ||
| 11 | DELPHI AUTOMOTIVE PLC | 10,065 | 863,000 | 0.13% | ||
| 12 | ARRAY BIOPHARMA INC | 215,000 | 907,000 | 0.13% | ||
| 13 | WABTEC CORP | 12,761 | 908,000 | 0.13% | ||
| 14 | MANNKIND CORP | 760,000 | 1,102,000 | 0.16% | Call | |
| 15 | LOXO ONCOLOGY INC COM | 45,000 | 1,280,000 | 0.19% | ||
| 16 | ProQR Therapeutics NV | 150,000 | 1,302,000 | 0.19% | ||
| 17 | Carbylan Therapeutics Inc. | 360,000 | 1,303,000 | 0.19% | ||
| 18 | Strongbridge Biopharma plc | 181,818 | 1,382,000 | 0.20% | ||
| 19 | NXP SEMICONDUCTORS N V | 16,920 | 1,426,000 | 0.21% | ||
| 20 | AXALTA COATING SYS LTD | 56,173 | 1,497,000 | 0.22% | ||
| 21 | ADR - Nabriva Therapeutics AG- Usd | 157,500 | 1,504,000 | 0.22% | ||
| 22 | NOVARTIS A G | 18,000 | 1,549,000 | 0.23% | ||
| 23 | TESARO INCORPORATED | 30,686 | 1,605,000 | 0.23% | ||
| 24 | Aldeyra Therapeutics Inc | 238,500 | 1,617,000 | 0.24% | ||
| 25 | GW PHARMACEUTICALS PLC | 23,790 | 1,652,000 | 0.24% | ||
| 26 | TRILLIUM THERAPEUTICS INC | 132,300 | 1,668,000 | 0.24% | ||
| 27 | OCERA THERAPEUTICS INC | 550,000 | 1,716,000 | 0.25% | ||
| 28 | Nivalis Therapeutics Inc | 231,548 | 1,792,000 | 0.26% | ||
| 29 | Pieris Pharmaceuticals | 810,000 | 1,855,000 | 0.27% | ||
| 30 | TOBIRA THERAPEUTICS INC | 187,622 | 1,886,000 | 0.28% | ||
| 31 | SCYNEXIS INC | 304,600 | 1,892,000 | 0.28% | ||
| 32 | EDGE THERAPEUTICS INC | 155,000 | 1,938,000 | 0.28% | ||
| 33 | AXSOME THERAPEUTICS INC COM | 220,000 | 2,009,000 | 0.29% | ||
| 34 | ABEONA THERAPEUTICS INC | 600,000 | 2,016,000 | 0.30% | ||
| 35 | ARBUTUS BIOPHARMA CORP | 454,500 | 2,023,000 | 0.30% | ||
| 36 | CYNAPSUS THERAPEUTICS INC | 134,037 | 2,070,000 | 0.30% | ||
| 37 | PALATIN TECHNOLOGIES INC COM | 3,132,926 | 2,080,000 | 0.30% | ||
| 38 | PTC THERAPEUTICS INC | 66,020 | 2,139,000 | 0.31% | ||
| 39 | VITAE PHARMACEUTICALS INC | 120,000 | 2,172,000 | 0.32% | ||
| 40 | DYNAVAX TECHNOLOGIES CORP | 90,000 | 2,174,000 | 0.32% | ||
| 41 | COGNIZANT TECHNOLOGY SOLUTIO | 36,600 | 2,197,000 | 0.32% | ||
| 42 | MEDICINES CO | 60,000 | 2,240,000 | 0.33% | ||
| 43 | DIMENSION THERAPEUTICS INC | 200,000 | 2,256,000 | 0.33% | ||
| 44 | FORWARD PHARMA A/S | 121,500 | 2,309,000 | 0.34% | ||
| 45 | SUMMIT THERAPEUTICS PLC | 202,220 | 2,321,000 | 0.34% | ||
| 46 | HALOZYME THERAPEUTICS INC | 135,000 | 2,340,000 | 0.34% | ||
| 47 | ADVANCE AUTO PARTS INC | 15,555 | 2,341,000 | 0.34% | ||
| 48 | COLUCID PHARMACEUTICALS ORD | 285,525 | 2,390,000 | 0.35% | ||
| 49 | EXELIXIS INC | 450,000 | 2,538,000 | 0.37% | ||
| 50 | UNIQURE NV | 153,500 | 2,539,000 | 0.37% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001178913-16-004256, filed 2016.02.11).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
